1. Home
  2. TRDA vs TRVG Comparison

TRDA vs TRVG Comparison

Compare TRDA & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • TRVG
  • Stock Information
  • Founded
  • TRDA 2016
  • TRVG 2005
  • Country
  • TRDA United States
  • TRVG Germany
  • Employees
  • TRDA N/A
  • TRVG N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • TRVG EDP Services
  • Sector
  • TRDA Health Care
  • TRVG Technology
  • Exchange
  • TRDA Nasdaq
  • TRVG Nasdaq
  • Market Cap
  • TRDA 235.4M
  • TRVG 278.1M
  • IPO Year
  • TRDA 2021
  • TRVG N/A
  • Fundamental
  • Price
  • TRDA $6.95
  • TRVG $3.22
  • Analyst Decision
  • TRDA Strong Buy
  • TRVG Buy
  • Analyst Count
  • TRDA 3
  • TRVG 4
  • Target Price
  • TRDA $25.67
  • TRVG $4.38
  • AVG Volume (30 Days)
  • TRDA 187.5K
  • TRVG 32.2K
  • Earning Date
  • TRDA 11-06-2025
  • TRVG 11-04-2025
  • Dividend Yield
  • TRDA N/A
  • TRVG N/A
  • EPS Growth
  • TRDA N/A
  • TRVG N/A
  • EPS
  • TRDA N/A
  • TRVG N/A
  • Revenue
  • TRDA $79,476,000.00
  • TRVG $592,176,160.00
  • Revenue This Year
  • TRDA N/A
  • TRVG $18.03
  • Revenue Next Year
  • TRDA N/A
  • TRVG $11.32
  • P/E Ratio
  • TRDA N/A
  • TRVG N/A
  • Revenue Growth
  • TRDA N/A
  • TRVG 7.39
  • 52 Week Low
  • TRDA $4.93
  • TRVG $1.64
  • 52 Week High
  • TRDA $21.79
  • TRVG $5.83
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 60.76
  • TRVG 52.08
  • Support Level
  • TRDA $6.60
  • TRVG $2.99
  • Resistance Level
  • TRDA $7.54
  • TRVG $3.29
  • Average True Range (ATR)
  • TRDA 0.43
  • TRVG 0.08
  • MACD
  • TRDA 0.06
  • TRVG 0.03
  • Stochastic Oscillator
  • TRDA 70.38
  • TRVG 76.67

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.

Share on Social Networks: